These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 10090670)
1. Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Shibata N; Hirano A; Kato S; Nagai R; Horiuchi S; Komori T; Umahara T; Asayama K; Kobayashi M Acta Neuropathol; 1999 Mar; 97(3):240-6. PubMed ID: 10090670 [TBL] [Abstract][Full Text] [Related]
2. Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation: immunohistochemical and immunoelectron microscopical analyses. Kato S; Horiuchi S; Nakashima K; Hirano A; Shibata N; Nakano I; Saito M; Kato M; Asayama K; Ohama E Acta Neuropathol; 1999 Mar; 97(3):260-6. PubMed ID: 10090673 [TBL] [Abstract][Full Text] [Related]
3. Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation. Kato S; Horiuchi S; Liu J; Cleveland DW; Shibata N; Nakashima K; Nagai R; Hirano A; Takikawa M; Kato M; Nakano I; Ohama E Acta Neuropathol; 2000 Nov; 100(5):490-505. PubMed ID: 11045671 [TBL] [Abstract][Full Text] [Related]
4. Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation. Kato S; Nakashima K; Horiuchi S; Nagai R; Cleveland DW; Liu J; Hirano A; Takikawa M; Kato M; Nakano I; Sakoda S; Asayama K; Ohama E Neuropathology; 2001 Mar; 21(1):67-81. PubMed ID: 11304045 [TBL] [Abstract][Full Text] [Related]
5. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Shibata N; Nagai R; Miyata S; Jono T; Horiuchi S; Hirano A; Kato S; Sasaki S; Asayama K; Kobayashi M Acta Neuropathol; 2000 Sep; 100(3):275-84. PubMed ID: 10965797 [TBL] [Abstract][Full Text] [Related]
6. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation. Kato S; Sumi-Akamaru H; Fujimura H; Sakoda S; Kato M; Hirano A; Takikawa M; Ohama E Acta Neuropathol; 2001 Sep; 102(3):233-8. PubMed ID: 11585247 [TBL] [Abstract][Full Text] [Related]
7. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis. Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124 [TBL] [Abstract][Full Text] [Related]
8. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389 [TBL] [Abstract][Full Text] [Related]
9. Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal model. Okamoto Y; Shirakashi Y; Ihara M; Urushitani M; Oono M; Kawamoto Y; Yamashita H; Shimohama S; Kato S; Hirano A; Tomimoto H; Ito H; Takahashi R PLoS One; 2011; 6(5):e20427. PubMed ID: 21655264 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions. Kato S; Saito M; Hirano A; Ohama E Histol Histopathol; 1999 Jul; 14(3):973-89. PubMed ID: 10425565 [TBL] [Abstract][Full Text] [Related]
11. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation. Shibata N; Hirano A; Hedley-Whyte ET; Dal Canto MC; Nagai R; Uchida K; Horiuchi S; Kawaguchi M; Yamamoto T; Kobayashi M Acta Neuropathol; 2002 Aug; 104(2):171-8. PubMed ID: 12111360 [TBL] [Abstract][Full Text] [Related]
12. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940 [TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. Ince PG; Tomkins J; Slade JY; Thatcher NM; Shaw PJ J Neuropathol Exp Neurol; 1998 Oct; 57(10):895-904. PubMed ID: 9786240 [TBL] [Abstract][Full Text] [Related]
14. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. Shibata N; Hirano A; Kobayashi M; Siddique T; Deng HX; Hung WY; Kato T; Asayama K J Neuropathol Exp Neurol; 1996 Apr; 55(4):481-90. PubMed ID: 8786408 [TBL] [Abstract][Full Text] [Related]
15. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Chou SM; Wang HS; Taniguchi A; Bucala R Mol Med; 1998 May; 4(5):324-32. PubMed ID: 9642682 [TBL] [Abstract][Full Text] [Related]